Atomera (ATOM) insider files Form 144 to sell 4,132 shares

Rhea-AI Filing Summary

Form 144 filed for Atomera Incorporated (ATOM) discloses a proposed sale of 4,132 common shares with an aggregate market value of $12,999.69, to be executed approximately on 09/03/2025 on NASDAQ. The shares were acquired as restricted stock from the issuer on 09/01/2025. The filing lists prior sales by the same individual: 3,601 shares sold on 09/02/2025 for $11,381.34 and 4,196 shares sold on 06/11/2025 for $25,729.03. The filer affirms there is no undisclosed material adverse information and the notice includes the standard Rule 144 representations.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice for small-volume insider sales, appears procedural and compliant.

The Form 144 documents a proposed sale of 4,132 common shares (about $13k) on NASDAQ and records recent small disposals by the same individual. The shares were acquired as restricted stock two days before the planned sale, and the filing includes the standard attestation of no undisclosed material information. From a compliance perspective, the form provides the required transactional details and dates for aggregation under Rule 144.

Equity Capital Markets Analyst

TL;DR: Insider sales are small relative to outstanding shares and unlikely to move market sentiment.

With 31,482,756 shares outstanding reported in the form, the proposed sale size (~4,132 shares, $13k) is immaterial in absolute and percentage terms. The filing notes recent sales totaling 7,797 shares in the past three months. These disclosures increase transparency about insider liquidity but do not disclose operational or financial developments.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4132	12999.69	31482756	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2025	Restricted Stock	ISSUER			4132	09/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT MEARS 750 University Avenue, Suite 280, Los Gatos CA 95032	Common	09/02/2025	3601	11381.34
ROBERT MEARS 750 University Avenue, Suite 280, Los Gatos CA 95032	Common	06/11/2025	4196	25729.03

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Atomera (ATOM) Form 144 disclose?

It discloses a proposed sale of 4,132 common shares valued at $12,999.69 to be sold on NASDAQ approximately on 09/03/2025.

When were the shares being sold acquired?

The shares were acquired as restricted stock on 09/01/2025 from the issuer, with payment/date recorded as 09/01/2025.

Has the filer sold other ATOM shares recently?

Yes. The filing lists prior sales of 3,601 shares on 09/02/2025 for $11,381.34 and 4,196 shares on 06/11/2025 for $25,729.03.

What exchange will the shares be sold on?

The proposed sale is reported to be executed on NASDAQ.

Does the filer state there is undisclosed material information?

The filer represents they do not know of any material adverse information that has not been publicly disclosed.